247 related articles for article (PubMed ID: 18321150)
1. Emerging drugs for malignant glioma.
Mason WP
Expert Opin Emerg Drugs; 2008 Mar; 13(1):81-94. PubMed ID: 18321150
[TBL] [Abstract][Full Text] [Related]
2. Novel therapeutics in adult malignant brain gliomas.
Reni M; Mazza E; Tosoni A; Brandes AA
Expert Opin Investig Drugs; 2005 Jun; 14(6):643-58. PubMed ID: 16004593
[TBL] [Abstract][Full Text] [Related]
3. Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux.
Lin F; de Gooijer MC; Hanekamp D; Brandsma D; Beijnen JH; van Tellingen O
CNS Oncol; 2013 May; 2(3):271-88. PubMed ID: 25054467
[TBL] [Abstract][Full Text] [Related]
4. Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective.
Poonan P; Agoni C; Ibrahim MAA; Soliman MES
Protein J; 2021 Oct; 40(5):601-655. PubMed ID: 34590194
[TBL] [Abstract][Full Text] [Related]
5. Cell surface receptors in malignant glioma.
Li YM; Hall WA
Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
[TBL] [Abstract][Full Text] [Related]
6. New developments in the treatment of malignant gliomas.
Soffietti R; Leoncini B; Rudà R
Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapies on the horizon for malignant glioma.
Hofer S; Stupp R
Target Oncol; 2010 Sep; 5(3):157-60. PubMed ID: 20827575
[No Abstract] [Full Text] [Related]
8. Emerging targeted treatments for malignant glioma.
Mulholland PJ; Thirlwell C; Brock CS; Newlands ES
Expert Opin Emerg Drugs; 2005 Nov; 10(4):845-54. PubMed ID: 16262566
[TBL] [Abstract][Full Text] [Related]
9. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Wen PY; Yung WK; Lamborn KR; Dahia PL; Wang Y; Peng B; Abrey LE; Raizer J; Cloughesy TF; Fink K; Gilbert M; Chang S; Junck L; Schiff D; Lieberman F; Fine HA; Mehta M; Robins HI; DeAngelis LM; Groves MD; Puduvalli VK; Levin V; Conrad C; Maher EA; Aldape K; Hayes M; Letvak L; Egorin MJ; Capdeville R; Kaplan R; Murgo AJ; Stiles C; Prados MD
Clin Cancer Res; 2006 Aug; 12(16):4899-907. PubMed ID: 16914578
[TBL] [Abstract][Full Text] [Related]
11. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP
Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.
da Fonseca CO; Landeiro JA; Clark SS; Quirico-Santos T; da Costa Carvalho Mda G; Gattass CR
Surg Neurol; 2006; 65 Suppl 1():S1:2-1:8; discussion S1:8-1:9. PubMed ID: 16427438
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.
Perry JR; Rizek P; Cashman R; Morrison M; Morrison T
Cancer; 2008 Oct; 113(8):2152-7. PubMed ID: 18756530
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor receptor alpha in glioma: a bad seed.
Liu KW; Hu B; Cheng SY
Chin J Cancer; 2011 Sep; 30(9):590-602. PubMed ID: 21880180
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy for malignant gliomas: an update].
Wakabayashi T; Natsume A; Fujii M
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1283-7. PubMed ID: 24105052
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic agents in the treatment of recurrent high-grade gliomas.
Brandes AA; Pasetto LM
Forum (Genova); 2000; 10(2):121-31. PubMed ID: 10875974
[TBL] [Abstract][Full Text] [Related]
17. Molecular targeted therapies and chemotherapy in malignant gliomas.
Brandsma D; van den Bent MJ
Curr Opin Oncol; 2007 Nov; 19(6):598-605. PubMed ID: 17906459
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future.
Cavaliere R; Newton H
Expert Opin Pharmacother; 2006 Apr; 7(6):749-65. PubMed ID: 16556090
[TBL] [Abstract][Full Text] [Related]
19. Non-cytotoxic drugs as potential treatments for gliomas.
Drappatz J; Wen PY
Curr Opin Neurol; 2004 Dec; 17(6):663-73. PubMed ID: 15542974
[TBL] [Abstract][Full Text] [Related]
20. Localized BCNU chemotherapy and the multimodal management of malignant glioma.
La Rocca RV; Mehdorn HM
Curr Med Res Opin; 2009 Jan; 25(1):149-60. PubMed ID: 19210148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
